{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:25:51Z","timestamp":1781007951973,"version":"3.54.1"},"reference-count":87,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.1080\/03007995.2024.2362278","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:23:44Z","timestamp":1717089824000},"page":"1221-1233","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis"],"prefix":"10.1080","volume":"40","author":[{"given":"Sobha","family":"Sivaprasad","sequence":"first","affiliation":[{"name":"NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Bailey","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol and Weston NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Downey","sequence":"additional","affiliation":[{"name":"Ophthalmology Research Team, Hull and East Yorkshire Hospital, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bayer PLC, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gale","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bayer PLC, Reading, UK"},{"name":"Ophthalmology and Clinical Visual Science, Hull York Medical School, University of York, York, UK"},{"name":"Department of Ophthalmology, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kotagiri","sequence":"additional","affiliation":[{"name":"Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, South Shields UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Manchester Eye Hospital, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Morgan-Warren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bayer PLC, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Napier","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bayer PLC, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirodhini","family":"Narendran","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK"},{"name":"School of Life and Health Sciences, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Rennie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Southampton NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Talks","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Wojcik","sequence":"additional","affiliation":[{"name":"Senior Leadership Team, Medialis Ltd, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7241-7476","authenticated-orcid":false,"given":"Ravi","family":"Jandhyala","sequence":"additional","affiliation":[{"name":"Senior Leadership Team, Medialis Ltd, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0383-5"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018289"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab259.133"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826010-00006"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-2836-0"},{"key":"e_1_3_5_7_1","unstructured":"The Royal College of Ophthalmologists. Commissioning Guidance: age Related Macular Degeneration Services. 2021."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197670"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2010.01546.x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2641-3"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01646-3"},{"key":"e_1_3_5_12_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Ranibizumab and pegaptanib for the treatment of age-related macular degeneration. [TA155]. Published August 27 2008. Accessed August 25 2023. https:\/\/www.nice.org.uk\/guidance\/ta155."},{"key":"e_1_3_5_13_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Age-related macular degeneration. NICE guideline [NG82]. Published January 23 2018. Accessed August 25 2023. https:\/\/www.nice.org.uk\/guidance\/ng82."},{"key":"e_1_3_5_14_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Aflibercept solution for injection for treating wet age\u2011related macular degeneration. [TA294]. Published July 24 2013. Accessed August 25 2023. https:\/\/www.nice.org.uk\/guidance\/ta294\/chapter\/4-Consideration-of-the-evidence."},{"key":"e_1_3_5_15_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Brolucizumab for treating wet age-related macular degeneration. [TA672]. Published February 3 2021. Accessed August 25 2023. https:\/\/www.nice.org.uk\/guidance\/ta672."},{"key":"e_1_3_5_16_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Faricimab for treating wet age-related macular degeneration. Technology appraisal guidance [TA800]. Published June 29 2022. Committee papers. Accessed August 25 2023. https:\/\/www.nice.org.uk\/guidance\/ta800\/evidence\/committee-papers-pdf-11127512989."},{"key":"e_1_3_5_17_1","unstructured":"National Health Service England. Operational note: Updated commissioning recommendations for medical retinal vascular medicines following the national procurement for ranibizumab biosimilars. Accessed August 25 2023. https:\/\/www.england.nhs.uk\/long-read\/operational-note-updated-commissioning-recommendations-for-medical-retinal-vascular-medicines-following-the-national-procurement-for-ranibizumab-biosimilars\/."},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.006"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00010-1"},{"key":"e_1_3_5_23_1","unstructured":"Medicines and Healthcare products Regulatory Agency. 2021. Summary of product characteristics [Eyelea]. Accessed August 25 2023. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/d24a783ac377311dea10a8fc983667447044d61a."},{"key":"e_1_3_5_24_1","unstructured":"Medicines and Healthcare products Regulatory Agency. 2021. Summary of product characteristics [Beovu]. Accessed August 25 2023. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/856fe193cab742573bd558275ed4a05dfa42c0aa."},{"key":"e_1_3_5_25_1","unstructured":"Medicines and Healthcare products Regulatory Agency. 2022. Summary of product characteristics [Vabysmo]. Accessed August 25 2023. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/cbe8dd3b2ac286047361d5ca94f2eba02db79878."},{"key":"e_1_3_5_26_1","unstructured":"Medicines and Healthcare products Regulatory Agency. 2021. Summary of product characteristics [Lucentis]. Accessed August 25 2023. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/8f9f82d6ec696188fc316bdef8ef2f7243a279f4."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3647-4"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.17925\/USOR.2023.17.1.8"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02153-9"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S275977"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02149-5"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.225"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.1"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02250-8"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2021.1931099"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2144054"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1734920"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1816946"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-021-01862-1"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-01947-z"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1961-9"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.343"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00768-z"},{"key":"e_1_3_5_47_1","unstructured":"British National Formulary (online). London: BMJ Group and Pharmaceutical Press. Updated September 2018. Available from: https:\/\/vnras.com\/wp-content\/uploads\/pdf\/BNF-76.pdf."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319506"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta18690"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.10.023"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02248-5"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129361"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19159488"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S233061"},{"key":"e_1_3_5_55_1","unstructured":"The Royal College of Ophthalmologists. National Ophthalmology Database Audit: The First Report of Age-related Macular Degeneration Audit (AMD). 2023. Available from: https:\/\/nodaudit.org.uk\/sites\/default\/files\/2023-02\/NOD%20AMD%20Audit%20Full%20Annual%20Report%202023_0.pdf."},{"key":"e_1_3_5_56_1","unstructured":"Macular Society. Treatments. 2022. Accessed September 1 2023. Available from: https:\/\/www.macularsociety.org\/diagnosis-treatment\/treatments\/."},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00715-y"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780170042004"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300161100"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.2165\/10899570-000000000-00000"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00942-2"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462308080203"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-021-01414-w"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216316670287"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2018-001519"},{"key":"e_1_3_5_66_1","unstructured":"Kaltenthaler E Tappenden P Paisley S et\u00a0al. NICE DSU Technical Support Document 13: Identifying and reviewing evidence to inform the conceptualisation and population of cost-effectiveness models: report by the Decision Support Unit. 2011. Available at: https:\/\/www.sheffield.ac.uk\/media\/34222\/download?attachment."},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00952-0"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13824"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.6591"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.04.014"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00771-y"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.06.011"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.123709.1"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.01.002"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.01.003"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462321001732"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.01.004"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta14250"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.04.009"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033294120954135"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-325"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015141"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0393-3"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2013.03.009"},{"key":"e_1_3_5_85_1","unstructured":"The Royal College of Ophthalmologists. Response from The Royal College of Ophthalmologists (RCOphth) to the HEE Strategic Framework Call for Evidence. 2021b. Available at: https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2021\/09\/RCOphth-response-to-HEE-Strategic-Framework-Call-for-Evidence-6-Sept-final-1.pdf."},{"key":"e_1_3_5_86_1","unstructured":"The Royal College of Ophthalmologists. Facing workforce shortages and backlogs in the aftermath or COVID-19: The 2022 census of the ophthalmology consultant trainee and SAS workforce. Census Report. Available at: https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2023\/03\/2022-Ophthalmology-census-Facing-workforce-shortages-and-backlogs-in-the-aftermath-of-COVID-19.pdf."},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0957-2"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta8490"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2362278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:35:57Z","timestamp":1727267757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2362278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":87,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1080\/03007995.2024.2362278"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2362278","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}